The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial

被引：0
|
作者：
Shabbir, S. [1 ]
Pouliquen, I. [2 ]
Bentley, J. H. [3 ]
Bradford, E. S. [4 ]
Kaisermann, M. C. [5 ]
Albayaty, M. [6 ]
机构：
[1] GSK, Clin Platforms & Sci PCPS, Global Clin Sci & Delivery GCSD R&D Projects, Stevenage, Herts, England
[2] GSK, Clin Pharmacol Modelling & Simulat, Uxbridge, Middx, England
[3] GSK, Clin Stat, Uxbridge, Middx, England
[4] GSK, Resp Therapeut Area, Res Triangle Pk, NC USA
[5] GSK, Resp Therapy Area, Collegeville, PA USA
[6] Northwick Pk Hosp & Clin Res Ctr, PAREXEL Early Phase Clin Unit, Harrow, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1311
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults
    Dorinsky, Paul
    DePetrillo, Paolo
    DeAngelis, Kiernan
    Trivedi, Roopa
    Darken, Patrick
    Gillen, Michael
    CLINICAL THERAPEUTICS, 2020, 42 (04) : 634 - 648
  • [32] Pharmacokinetics and bioequivalence assessment of optimized directly compressible Aceclofenac (100 mg) tablet formulation in healthy human subjects
    Bushra, Rabia
    Shoaib, Muhammad Harris
    Ali, Huma
    Ghayas, Sana
    PLOS ONE, 2020, 15 (09):
  • [33] Pharmacokinetics, bioavailability, and bioequivalence of lower-sodium oxybate in healthy participants in two open-label, randomized, crossover studies
    Chen, Cuiping
    Jenkins, Jack
    Zomorodi, Katie
    Skowronski, Roman
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2278 - 2287
  • [34] A Randomized Phase I Study Comparing Pharmacokinetics, Safety and Immunogenicity of High Concentration Formulation (100 mg/mL) With GP2017 Formulation (50 mg/mL), an Adalimumab Biosimilar, in Healthy Male Subjects
    Rondon, Juan Carlos
    Von Richter, Oliver
    Fey, Constanze
    Fan, Jamie
    Furlan, Fabricio
    Lemke, Lena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S765 - S766
  • [35] Effect of opicapone and entacapone on levodopa pharmacokinetics when administered with immediate release 100/25 mg levodopa/carbidopa in healthy subjects
    Rocha, J. F.
    Falcao, A.
    Pinto, R.
    Nunes, T.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2013, 28 : S155 - S155
  • [36] AN ORALLY ADMINISTERED ROBOTIC PILL (RP) RELIABLY AND SAFELY DELIVERS AN USTEKINUMAB BIOSIMILAR WITH HIGH BIOAVAILABILITY RELATIVE TO SUBCUTANEOUS (SC) USTEKINUMAB IN HEALTHY HUMAN PARTICIPANTS
    Myers, Joshua
    Nguyen, Son
    Patel, Nidhi
    Vo, April T.
    Yamaguchi, Alyson
    Horlen, Kyle
    Syed, Baber
    Van Dam, Jacques
    Imran, Mir
    Hashim, Mir A.
    Dhalla, Arvinder K.
    GASTROENTEROLOGY, 2024, 166 (05)
  • [37] Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1)
    Aslanis, Vassilios
    Abd-Elaziz, Khalid
    Slack, Robert J.
    Brinch, Anne
    Gravelle, Lise
    Morley, Wayne
    Phung, De
    Herman, Kimberly
    Holyer, Ian
    Poulsen, Karen Killerup
    Dogterom, Peter
    Tantawi, Susan
    Zetterberg, Fredrik R.
    Jacoby, Brian
    Schambye, Hans
    Lindmark, Bertil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (05) : 707 - 720
  • [38] Pharmacokinetics, Pharmacodynamics, and Comparative Bioavailability of Single, Oral 2-mg Doses of Dexamethasone Liquid and Tablet Formulations: A Randomized, Controlled, Crossover Study in Healthy Adult Volunteers
    Queckenberg, Christian
    Wachall, Bertil
    Erlinghagen, Valerie
    Di Gion, Paola
    Tomalik-Scharte, Dorota
    Tawab, Mona
    Gerbeth, Kathleen
    Fuhr, Uwe
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1831 - 1841
  • [39] COMPARABLE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ETROLIZUMAB ADMINISTERED VIA PREFILLED SYRINGE OR AUTOINJECTOR IN A RANDOMIZED TRIAL IN HEALTHY VOLUNTEERS.
    Zhang, W.
    Tyrrell, H.
    Abouhossein, M.
    Boruvka, A.
    Pulley, J.
    Ding, H.
    Ravanello, R.
    Erickson, R.
    Tang, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S37 - S38
  • [40] THE BIOAVAILABILITY OF AN ORAL LIQUID FORMULATION (OLF) RELATIVE TO A FORMULATED CAPSULE (FC) OF CRIZOTINIB, A DUAL ALK/MET INHIBITOR, IN HEALTHY SUBJECTS
    Xu, H.
    O'Gorman, M.
    Tan, W.
    Leister, C.
    Monajati, M.
    Brega, N.
    Ni, G.
    Phillips, S.
    da Costa, L. Mendes
    Bello, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S23 - S23
12345